UM  > 中華醫藥研究院
China’s landscape in oncology drug research: Perspectives from research collaboration networks
You H.2; Ni J.2; Barber M.1; Scherngell T.1; Hu Y.2
Source PublicationChinese Journal of Cancer Research
ISSN19930631 10009604
AbstractObjective: Better understanding of China’s landscape in oncology drug research is of great significance for discovering anti-cancer drugs in future. This article differs from previous studies by focusing on Chinese oncology drug research communities in co-publication networks at the institutional level. Moreover, this research aims to explore structures and behaviors of relevant research units by thematic community analysis and to address policy recommendations. Methods: This research used social network analysis to define an institutions network and to identify a community network which is characterized by thematic content. Results: A total of 675 sample articles from 2008 through 2012 were retrieved from the Science Citation Index Expanded (SCIE) database of Web of Science, and top institutions and institutional pairs are highlighted for further discussion. Meanwhile, this study revealed that institutions based in the Chinese mainland are located in a relatively central position, Taiwan’s institutions are closely assembled on the side, and Hong Kong’s units located in the middle of the Chinese mainland’s and Taiwan’s. Spatial division and institutional hierarchy are still critical barriers to research collaboration in the field of anti-cancer drugs in China. In addition, the communities focusing on hot research areas show the higher nodal degree, whereas communities giving more attention to rare research subjects are relatively marginalized to the periphery of network. Conclusions: This paper offers policy recommendations to accelerate cross-regional cooperation, such as through developing information technology and increasing investment. The brokers should focus more on outreach to other institutions. Finally, participation in topics of common interest is conducive to improved efficiency in research and development (R&D) resource allocation.
KeywordAnti-cancer Pharmaceuticals Publications Research collaboration networks Thematic analysis
URLView the original
被引频次[WOS]:2   [WOS记录]     [WOS相关记录]
Document TypeJournal article
专题Institute of Chinese Medical Sciences
Affiliation1.Austrian Institute of Technology
2.Universidade de Macau
GB/T 7714
You H.,Ni J.,Barber M.,et al. China’s landscape in oncology drug research: Perspectives from research collaboration networks[J]. Chinese Journal of Cancer Research,2015,27(2):138-147.
APA You H.,Ni J.,Barber M.,Scherngell T.,&Hu Y..(2015).China’s landscape in oncology drug research: Perspectives from research collaboration networks.Chinese Journal of Cancer Research,27(2),138-147.
MLA You H.,et al."China’s landscape in oncology drug research: Perspectives from research collaboration networks".Chinese Journal of Cancer Research 27.2(2015):138-147.
Google Scholar
中相似的文章 Google Scholar
[You H.]的文章
[Ni J.]的文章
[Barber M.]的文章
Baidu academic
中相似的文章 Baidu academic
[You H.]的文章
[Ni J.]的文章
[Barber M.]的文章
Bing Scholar
中相似的文章 Bing Scholar
[You H.]的文章
[Ni J.]的文章
[Barber M.]的文章
所有评论 (0)